Reuters logo
BRIEF-GlaxoSmithKline says European Commission grants marketing authorisation for Trelegy Ellipta
November 16, 2017 / 7:43 AM / in a month

BRIEF-GlaxoSmithKline says European Commission grants marketing authorisation for Trelegy Ellipta

Nov 16 (Reuters) - Glaxosmithkline Plc

* TRELEGY ELLIPTA ONCE-DAILY SINGLE INHALER TRIPLE THERAPY GAINS MARKETING AUTHORISATION IN EUROPE FOR TREATMENT OF COPD​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below